Category: Medmonitor

92 posts found

Medmonitor

COVID-19 Pill Approval and More Updates

Molnupiravir, Paxlovid, and AZD7442 have shown promise in Phase 3 trials.

Medmonitor

FDA Approves Zimhi and Seglentis

A new naloxone drug and a new opioid-NSAID combination.

Medmonitor

New Drugs, Generics, and a COVID-19 Treatment Update

A new migraine medication, various generics, and more.

Medmonitor

FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way

The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.

Medmonitor

New Generic Approvals

The FDA approved first-time generics for Xeljanz, two COPD medications, and more.

Medmonitor

FDA and CDC: Vaccinated Adults Will Not Need COVID-19 Booster Shots

A joint statement announces that at this time, vaccinated adults are protected from the Delta variant.

Medmonitor

FDA Approves First New Weight Loss Drug Since 2014, Issues EUA for COVID-19 Antibody

Wegovy (semaglutide) and sotrovimab will soon be available.

Medmonitor

FDA Approves Kloxxado for Opioid Overdose

A new 8 mg naloxone nasal spray will soon be available, which is the largest naloxone dose approved by the FDA to date.

Medmonitor

FDA and CDC Recommend Resuming Use of Johnson & Johnson COVID-19 Vaccine

After reviewing six rare cases of blood clots after 7 million doses, current data indicates the vaccine is safe.

Medmonitor

FDA Approves New Acetaminophen Injection Dose

A new 500mg injection will soon be available.

Medmonitor

FDA Approves Posimir for Post-Surgical Pain Relief

A novel bupivacaine formulation works as a 72-hour local anesthetic following shoulder surgery.

Medmonitor

COVID-19 Mutations Impact Testing

False negatives may be reported due to genetic variations of the virus.

Medmonitor

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.

Medmonitor

FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.

Medmonitor

FDA Requires Boxed Warning Update for Benzodiazepines

Even at recommended doses, benzodiazepine use can lead to misuse, abuse, and addiction.

Prev 1 2 3 4 5 6 7 Next